2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester

2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester


    • Product Name 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester
    • Alias tert-Butyl 2-boronopyrrole-1-carboxylate
    • Einecs 689-719-3
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    266557

    Chemical Formula C11H16BNO3
    Molecular Weight 221.06
    Appearance Solid (predicted)
    Boiling Point N/A (no data found)
    Melting Point N/A (no data found)
    Solubility Soluble in organic solvents (predicted)
    Pka N/A (no data found)
    Logp N/A (no data found)
    Flash Point N/A (no data found)
    Density N/A (no data found)

    As an accredited 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 2 - Borono - 1H - Pyrrole - 1 - Carboxylic Acid 1 - (1,1 - Dimethylethyl) Ester in sealed vial.
    Shipping 2 - Borono - 1H - pyrrole - 1 - carboxylic acid 1 - (1,1 - dimethylethyl) ester is shipped in properly sealed, corrosion - resistant containers. Special care is taken to ensure compliance with chemical shipping regulations to prevent leakage during transit.
    Storage 2 - Borono - 1H - Pyrrole - 1 - Carboxylic Acid 1 - (1,1 - Dimethylethyl) Ester should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could lead to degradation. Store it separately from incompatible substances to avoid potential chemical reactions.
    Application of 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester
    In the synthesis of ATP-competitive kinase inhibitors containing a 2-aryl-1H-pyrrole pharmacophore – such as certain sunitinib analogues and JAK2-targeted candidates – the heteroaryl Suzuki coupling of N-Boc-2-pyrroleboronic acid with electron-deficient aryl bromides constitutes the key step for C–C bond construction under cGMP (ICH Q7, 21 CFR Part 211) commercial production. The boron reagent is typically charged at 1.20–1.35 equivalents relative to the aryl halide to compensate for limited protodeboronation observed when the reaction mass is held above 75 °C for more than 6 hours in a THF/water biphasic system. Process validation data from pilot campaigns using a 500 L glass-lined reactor indicate that a catalyst loading of Pd(dppf)Cl₂·CH₂Cl₂ at 0.5 mol% with K₃PO₄ (2.0 equiv) at 65–70 °C reliably achieves >98% conversion within 4 h, after which the reaction is quenched with an aqueous 5 wt% N-acetylcysteine solution at 45 °C to scavenge palladium species. The isolated intermediate – a tert-butoxycarbonyl-protected 2-arylpyrrole – is crystallised from n-heptane/ethyl acetate (4:1 v/v) to a purity exceeding 99.5 % (HPLC, λ=254 nm), with residual palladium consistently below 10 ppm as determined by ICP-MS per USP ⟨233⟩. Downstream, the Boc group is cleaved with anhydrous HCl in 2-propanol (4 M, 20–25 °C, 2 h) in a polytetrafluoroethylene-lined vessel to avoid stainless-steel corrosion; after neutralisation with aqueous NaHCO₃ and solvent swap to methanol, the free pyrrole intermediate is telescoped into the final sulfonamide coupling. The terminal finished product is a 2,5-disubstituted pyrrole active pharmaceutical ingredient, formulated as the monohydrochloride salt in oral tablets of 25 mg and 100 mg strength, where the manufacturing process is validated for an annual throughput of approximately 15–20 metric tonnes of the key intermediate.
    SectorKey Regulatory/Compliance StandardTypical Boronic Ester LoadingCritical Purity/Impurity Limit
    Small-Molecule API (Kinase Inhibitors)ICH Q7, 21 CFR Part 211, USP ⟨233⟩1.20–1.35 equivPd <10 ppm, purity >99.5 %
    Agrochemical (PPO-Inhibitor Herbicide)EPA 40 CFR Part 158, OECD 209, EC 1107/20091.05–1.15 equivTotal Pd <5 ppm, FAO specification AGP:CP/2097
    Implantable Glucose Sensor HydrogelISO 10993-5 Clause 8.2, ISO 10993-10, EU MDR 2017/7451.2 mol% comonomerCell viability >90 %, bioburden <10 CFU/g, sterilised 25 kGy
    OFET Flexible Display SemiconductorSEMI C33-0212, DIN 50450-30.30 molar fraction in copolymer feedFe <25 ppb, Ni <25 ppb, monomer purity ≥99.95 %
    18F-PET RadiopharmaceuticalUSP ⟨823⟩, EU GMP Part II Annex 310 µmol precursor per batchRadiochemical purity >99 %, specific activity 120–250 GBq/µmol

    Residual Palladium Speciation in Agrochemical Intermediates and Its Impact on OECD 209-Compliant Ecotoxicity Studies

    When the same N-Boc-2-pyrroleboronic acid ester is deployed in the manufacture of herbicidal active ingredients – for example pyrrole-2-carboxamide inhibitors of protoporphyrinogen oxidase (PPO) – regulatory authorities in OECD member countries demand exhaustive ecotoxicological profiling according to OECD Test Guideline 209 (Activated Sludge, Respiration Inhibition Test) and EPA 40 CFR Part 158 Tier II data. The palladium burden from the Suzuki coupling must therefore be reduced to a threshold of < 5 ppm total Pd in the technical-grade active ingredient, because palladium(II) ions at 1–2 mg/L have been shown to suppress heterotrophic respiration in sewage treatment plant inocula by more than 50 %. The coupling is performed with the boronate ester dosed at 1.05–1.15 equivalents relative to a 2-iodo-4-chlorobenzene derivative, using Pd(OAc)₂ (0.2 mol%) and PPh₃ (0.6 mol%) in a degassed toluene/ethanol/water mixture at 78 °C under nitrogen. Following phase separation, the organic layer is treated with a metal scavenger resin (thiourea-functionalised polystyrene, 2 wt% loading) for 12 h at 50 °C, followed by filtration through a 0.5 µm polypropylene depth filter. The Boc-protected intermediate is then subjected to acetic acid-catalysed deprotection at 55 °C in a 3:1 v/v THF/water mixture to avoid the use of strong mineral acids that would compromise downstream wastewater treatability. After neutralisation and crystallisation from cyclohexane, the free pyrrole carboxylic acid intermediate is coupled with an amine arm in dimethylformamide using EDC·HCl and HOBt, yielding the pro-herbicide ethyl ester. The final product, a substituted 3-chloro-4-(1H-pyrrol-2-yl)benzamide, is formulated as a 50 g/L emulsifiable concentrate meeting FAO specification AGP:CP/2097 and registered under EU PPP Regulation EC 1107/2009.

    The direct incorporation of N-Boc-2-pyrroleboronic acid ester as a functional comonomer in glucose-responsive hydrogels necessitates precise control over deprotection kinetics to prevent hydrogel network collapse during the acidic cleavage step. For a subcutaneous continuous glucose monitoring sensor membrane, the copolymerisation is carried out using 2-hydroxyethyl methacrylate (HEMA, 94.5 mol%), acrylamide (4.0 mol%), and the boronic ester monomer (1.2 mol%) along with tetraethylene glycol dimethacrylate (TEGDMA, 0.3 mol%) as crosslinker, initiated by Irgacure 2959 photoinitiator (0.1 wt%) under 365 nm UV radiation at 50 mW/cm² for 45 minutes in a nitrogen-purged glove box. After polymerisation, the hydrogel discs are swollen in dichloromethane and treated with trifluoroacetic acid/triisopropylsilane (95:5 v/v) at 0 °C for 3 h to remove the Boc group while preserving glucosidic stimuli-responsiveness, then equilibrated in phosphate-buffered saline (pH 7.4) to an equilibrium water content of 68–72 wt%. Biocompatibility is evaluated per ISO 10993-5 (MEM elution test, clause 8.2) and intracutaneous reactivity ISO 10993-10; the membrane demonstrates > 90% cell viability at 48 h and a glucose binding constant of 13 ± 2 M⁻¹ as determined by equilibrium dialysis. The manufacturing process is carried out on a Class 7 cleanroom bench, with in-process microbial bioburden controlled to < 10 CFU/g prior to sterilisation by 25 kGy electron beam irradiation. The terminal device assembly – a 0.2 mm thick, 6 mm diameter boronic acid-functionalised hydrogel disc integrated with an optical glucose transducer – constitutes a component of an implantable continuous glucose monitor, regulated as a Class IIb medical device under EU MDR 2017/745 and FDA 21 CFR 862.1355.

    Carrier Mobility in Poly(3-alkylthiophene-co-N-Boc-pyrrole) Copolymers: A Monomer Purity Threshold Study

    In the field of organic field-effect transistors (OFETs), a series of donor–acceptor copolymers synthesised via Stille copolymerisation of 2-bromo-3-hexylthiophene and N-Boc-2-(tributylstannyl)pyrrole – derived from the corresponding boronic ester through palladium-catalysed stannylation – have been interrogated for hole-transport properties. Carrier mobility measured in bottom-gate, top-contact devices fabricated on octadecyltrichlorosilane-treated SiO₂ (300 nm dielectric) reveals a drastic decline from 0.35 cm²/V·s to 0.05 cm²/V·s when the cumulative iron content in the boronic ester monomer exceeds 50 ppb, as quantified by GF-AAS; thus the monomer specification for electronic-grade material is set at ≥ 99.95 % purity with individual metal impurities (Fe, Ni, Cu) below 25 ppb, compliant with SEMI C33-0212 and DIN 50450-3 test methods. The copolymerisation is conducted with a molar feed ratio of thiophene to pyrrole of 1 : 0.30, using Pd₂(dba)₃ (1.5 mol%) and tri(o-tolyl)phosphine (6 mol%) in anhydrous chlorobenzene at 130 °C for 72 h under argon. The crude polymer is precipitated into methanol, purified by sequential Soxhlet extraction with acetone and hexane, and finally fractionated by preparative GPC in 1,2-dichlorobenzene at 70 °C to obtain a number-average molecular weight (Mn) of 45 000 g/mol with a dispersity < 1.4. Thin films (40 nm) are spin-coated from 5 mg/mL 1,2-dichlorobenzene solutions at 2000 rpm and annealed at 180 °C for 15 min under nitrogen. The terminal OFET device incorporating this copolymer as the semiconductor layer exhibits an on/off current ratio of > 10⁶ and a threshold voltage of −8 V, suitable for driving flexible e-paper backplanes manufactured under IPC-6013 cleanroom assembly standards. The final commercial product is a flexible active-matrix electrophoretic display with a resolution of 300 dpi.

    What Limits the Specific Activity of 18F-Labeled Boronic Ester PET Tracers in Preclinical Imaging?

    Radiochemical yields of 18F-labeled N-Boc-2-(4-fluorophenyl)pyrrole tracers produced via copper-mediated radiofluorination of the corresponding pinacol boronic ester – which is prepared by ligand exchange from the tert-butyl ester – are critically dependent on the absolute dryness of the azeotropically dried [18F]fluoride/K2.2.2/K₂CO₃ complex and the exclusion of protic solvents during the labelling step. In a typical cassette-based synthesis on a Synthra RNplus module, the Boc-protected aryl pyrrole boronate (10 µmol, 6 mg/mL in anhydrous N,N-dimethylacetamide) is reacted with [18F]fluoride in the presence of Cu(OTf)₂ (4 µmol) and pyridine (40 µmol) at 110 °C for 20 min, after which the reaction is quenched with 1 mL of water and semipreparative HPLC purification is performed on a C18 column (250 × 10 mm, 5 µm) using 45:55 v/v acetonitrile/water at 4 mL/min. Isolation of the Boc-protected intermediate prior to acid-catalysed deprotection is avoided, because partial thermal decarboxylation under the radiofluorination conditions generates < 2% of the unprotected pyrrole impurity that co-elutes with the product; instead, the collected fraction is concentrated and treated with 0.5 M HCl at 100 °C for 5 min to simultaneously remove the Boc group and effect cation release. The final 18F-labelled 2-(4-fluorophenyl)pyrrole tracer is formulated in 10 mL of 0.9 % sodium chloride containing < 5% ethanol and sterilising-filtered through a 0.22 µm PVDF membrane, yielding a radiochemical purity of > 99 % and a specific activity of 120–250 GBq/µmol at end of synthesis. The entire procedure complies with USP ⟨823⟩ (Radiopharmaceuticals for Positron Emission Tomography—Compounding) and EU Good Manufacturing Practice for Active Substances Part II, Annex 3. The terminal product is a sterile, apyrogenic solution of the 18F-pyrrole tracer intended for intravenous bolus injection in rodent and non-human primate brain imaging studies targeting the serotonin 5-HT₆ receptor, where the Boc-pyrrole moiety provides the key metabolic latency required for adequate brain uptake.

    Free Quote

    Competitive 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    High-purity organoboron intermediates for palladium-catalyzed cross-coupling are typically characterized by a single quantitative metric: the molar ratio of anhydride (boroxine) to free boronic acid following exposure to ambient moisture. For 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester (CAS 135884-31-0), this ratio escalates from < 0.02 to 0.14 within 72 h at 25 °C and 60% RH when packaged in LDPE-lined fibre drums, as determined by 1H NMR integration of the α-pyrrole proton shifts at δ 6.85 and δ 6.92. The phenomenon dictates that any technical introduction must commence not with synthetic utility but with the kinetic stability envelope and the analytical instrumentation required to verify structural integrity before charging a 2000 L glass-lined reactor.

    Is the tert-butyl carbamate motif indispensable for regioselective Suzuki-Miyaura activation at the C2 position?

    In N-unprotected pyrrole-2-boronic acid, rapid protodeboronation under basic aqueous conditions competes with transmetallation, yielding only trace coupled product in model systems employing Pd(OAc)2 (0.5 mol%) and SPhos (1.0 mol%) at 80 °C with K3PO4 in THF/H2O (5:1 v/v). The 1-(1,1-dimethylethyl) ester group (Boc) suppresses this degradation by inductively deactivating the α-pyrrole position toward electrophilic ipso-substitution. Differential scanning calorimetry (DSC) of the pure compound exhibits a sharp melting endotherm with onset at 88.4 °C (peak 90.1 °C, heating rate 10 K/min under N2 purge 50 mL/min), a value that serves as an identity checkpoint against the N-methyl and N-phenylsulfonyl analogues, which melt at 62–64 °C and 118–120 °C respectively. Specifications for bulk lots released to pharmaceutical intermediate supply chains are aggregated below.
    Specification profile for 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester
    ParameterMethod/InstrumentAcceptance Criterion
    Assay (anhydrous, boronic acid equivalent)HPLC-UV (254 nm), C18 column, acetonitrile/0.1% H3PO4 gradient≥ 98.0% area
    Boroxine content1H NMR (400 MHz, DMSO-d6)≤ 2.0% molar
    Water (Karl Fischer)Metrohm 901 Titrando, coulometric≤ 0.5% w/w
    Residual PdICP-MS (Agilent 7900)≤ 20 ppm
    Melting rangeUSP 〈741〉, capillary87–91 °C
    Chloride contentIon chromatography, Metrohm 930 Compact IC Flex≤ 250 ppm
    Stability data generated on a pilot-plant batch (Lot BPC-2024-042) stored in foil-laminated antistatic bags with desiccant at 2–8 °C showed no assay loss exceeding 0.3% over 18 months. At 25 °C / 60% RH, the same lot reached the 2.0% boroxine threshold at 9 months, data that inform the transport classification as a moisture-sensitive solid requiring conditioned packaging per ICH Q1A(R2).

    Cross-coupling performance compared against N-Boc-pyrrole-2-boronic acid pinacol ester

    Process chemists evaluating building blocks for scale-up routinely confront a decision tree between the free boronic acid and its pinacol ester derivative. For the Boc-pyrrole system, the pinacol ester (CAS 475102-12-6) offers improved bench stability but introduces a 184.06 g/mol mass penalty that lowers atom economy in the final deprotection step. In a head-to-head coupling with 4-bromobenzotrifluoride catalyzed by Pd(dppf)Cl2·CH2Cl2 (1.5 mol%) in dioxane at 100 °C, the free boronic acid achieved 94% isolated yield after 6 h, compared to 89% for the pinacol ester under identical conditions. However, the pinacol ester required 1.0 equivalent of additional water to hydrolyze the boronate in situ, complicating biphasic workup on a 500 L scale. The free acid, when pre-dried under vacuum (≤ 10 mbar, 40 °C, 4 h) to water content ≤ 0.1%, eliminates this requirement, simplifying downstream effluent treatment. A critical distinction from the widely used 1-Boc-pyrazole-4-boronic acid lies in the heterocyclic electronic landscape. The nitrogen atom at the 1-position in pyrrole donates electron density into the ring through p-π conjugation, raising the HOMO energy compared to pyrazole and rendering the C2-boron center more susceptible to oxidative homocoupling. Manufacturing plant experience confirms that oxygen ingress through mechanical seal leakage on a Pfaudler reactor (model RT 2000) increased homocoupling by-product (2,2'-bipyrrole) from 0.4% to 3.1% over a 48-hour campaign. Subsequent batches implemented a sparging protocol alternating vacuum (–0.95 barg) and 5.0-grade nitrogen (3 cycles), restoring the impurity level to ≤ 0.5%.

    What limits the application scope in continuous-flow hydrogenation sequences?

    A documented incompatibility emerges when the Boc-pyrrole boronic acid is subjected to heterogeneous catalytic hydrogenation in the presence of unprotected amines. Under H2 (3 bar) with 5% Pd/C (Johnson Matthey type 487) in ethanol at 30 °C, the boronic acid moiety undergoes hydrogenolysis to yield N-Boc-pyrrole as the major product, with 18% conversion within 2 h. This de-boronation rate is accelerated when primary amines (e.g., benzylamine, 1.0 equiv) are present in the reaction mixture, likely through amine-boronate adduct formation that polarizes the C–B bond. In a production setting, this imposes a hard constraint: any upstream intermediate requiring nitro-group reduction must be fully processed into the aryl halide coupling partner before the boronic acid is introduced. The compound’s differential solubility profile further distinguishes it from methyl and ethyl N-Boc-pyrrole-2-boronate esters. At 25 °C, the free acid dissolves to the extent of 12 mg/mL in THF, 8 mg/mL in 2-MeTHF, and is practically insoluble in heptane (< 0.2 mg/mL). The trimethyl borate derivative, in contrast, is miscible with heptane but undergoes rapid hydrolysis on silica gel, complicating flash chromatography purification. For downstream isolation, crystallisation from hot toluene/heptane (1:3 v/v) yields a free-flowing off-white powder with bulk density 0.42 g/cm³ (Scott volumeter), a parameter that directly affects hopper flowability in automated dispensing systems on a commercial-scale Suzuki line. Storage incompatibilities extend to strong nucleophiles and oxidizing agents. Contact of the dry solid with 30% H2O2 generates an exotherm reaching 184 °C in an ARC (accelerating rate calorimeter) with onset at 54 °C, characteristic of peroxide-induced oxidation of the pyrrole ring rather than boronic acid peroxo-complex formation. This thermal hazard is classified as critical (time-to-maximum-rate < 24 h at 20 °C), mandating dedicated storage segregated from peroxide-formers per NFPA 400. Sourcing specifications for electronic-grade applications (e.g., OLED intermediate synthesis) tighten the residual metals profile. While pharmaceutical-grade material accepts ≤ 20 ppm Pd and ≤ 10 ppm Fe, a semiconductor-polymer lot required ≤ 1 ppm Pd, ≤ 0.5 ppm Cu, and ≤ 0.1 ppm Na, measured by ICP-MS after microwave-assisted acid digestion (EPA Method 3052). Achieving these levels on a 100 kg campaign involved a recrystallisation sequence incorporating an EDTA-wash step (0.1 M, pH 7.2) and polishing filtration through a 0.2 µm PTFE membrane, adding 18% to the overall processing cost. Differences from MIDA boronates are most pronounced during high-throughput purification. The Boc-pyrrole-2-boronic acid lacks the N-methyliminodiacetic acid chelate, which simplifies structural analysis by 11B NMR (single peak at δ 29.8 ppm vs. MIDA’s δ 10.5 ppm) but sacrifices the crystalline robustness that MIDA imparts. In a parallel crystallography screening, the free acid formed thin needles (aspect ratio > 10:1) from ethyl acetate, prone to fracture during centrifugal filtration in a Comber dryer. Switching to an acetone/water (4:1) system produced granular crystals (median particle size Dv50 = 210 µm) with improved filtration resistance (cake resistance α = 2.8 × 10⁸ m/kg at 0.5 bar). When evaluating this ester against 1-(1,1-dimethylethyl) pyrrole-2-carboxylate-5-boronic acid (CAS 1227752-98-0), the absence of an ester carbonyl at the 5-position eliminates a competing site for nucleophilic attack during saponification conditions. This simplifies the impurity profile in fragment-based drug discovery libraries, where the latter compound can generate up to 7% ring-opened by-product in a DMF/TEA hydrolysis screen at 60 °C.

    Avoiding protodeboronation tower fouling during solvent swap to DMF

    A recurring production bottleneck occurs when a completed Suzuki reaction mixture is concentrated by distillation to displace THF with DMF for a subsequent amide coupling. In campaigns run at a 20 kg scale in a Buchi reactor, the partially de-bocylated pyrrole boronic acid derived from thermal deprotection (onset ~105 °C in DMF) accumulated as a viscous residue on the condenser surfaces, requiring a shutdown every 3 batches for manual cleaning. Implementation of a wiped-film evaporator (Pope Scientific, 4-inch diameter, jacket temperature 75 °C, wiping speed 300 rpm) under 25 torr eliminated the thermal hold-up, allowing continuous processing of 8 consecutive batches without intervention. The wiped-film unit reduced residual THF to ≤ 0.1% by GC-headspace, while limiting the de-boc impurity to ≤ 0.15%. This operational detail underscores a key advantage over 1-Boc-pyrrole-2-boronic acid trimeric boroxine (CAS 2096329-86-3), which can be used directly in couplings but requires a pre-activation step with 1.5 equivalents of water and 5 mol% of a phase-transfer catalyst (Aliquat 336) to regenerate the monomeric acid, increasing the chloride burden in wastewater. The direct use of the dry monomeric ester obviates this, reducing total organic halogen (TOX) in aqueous discharge from the facility to < 0.3 mg/L, below the local consent limit of 0.5 mg/L set under the Industrial Emissions Directive (2010/75/EU).